Skip to main content

Table 1 Clinicopathological characteristics statistics of BLCA patients from TCGA

From: The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma

Clinicopathological characteristics CDCA3 expression level Total P value
Low High
Overall 211 165 376  
Gender    
 Female 59 (27.96%) 39 (23.64%) 98 0.3430
 Male 152 (72.04%) 126 (76.36%) 278
Grade     
 Low 17 (8.06%) 3 (1.82%) 20 0.0075**
 High 194 (91.94%) 162 (98.18%) 356
Stage     
 I + II 58 (27.49%) 60 (36.36%) 118 0.0657
 III + IV 153 (72.51%) 105 (63.64%) 258
T stage     
 T0 + T1 + T2 72 (34.12%) 50 (30.30%) 147 0.4324
 T3 + T4 139 (65.88%) 115 (69.70%) 229
M stage     
 M0 110 (52.13%) 70 (42.42%) 180 0.0615
 M1 + MX 101 (47.87%) 95 (57.58%) 196
N stage     
 N0 128 (60.66%) 96 (58.18%) 224 0.6265
 N1 + N2 + NX 83 (39.34%) 69 (41.82%) 152